Wen-Chun Kuo

Title: Innovations of Wen-Chun Kuo in Biotech

Introduction

Wen-Chun Kuo is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly through his innovative work on peptides. His research focuses on enhancing the functionality of human acidic fibroblast growth factor, which has implications for various medical applications.

Latest Patents

Wen-Chun Kuo holds a patent for a modified peptide of human acidic fibroblast growth factor (aFGF). This patent describes a modified peptide that comprises a native human aFGF shortened by a deletion of 20 amino acids from the N-terminal of the native human aFGF. Additionally, it includes the addition of Alanine (Ala) before the shortened native aFGF. This innovation could lead to advancements in therapeutic applications.

Career Highlights

Kuo is currently associated with Eu Sol Biotech Co., Ltd., where he continues to explore and develop biotechnological solutions. His work has garnered attention for its potential to improve medical treatments and enhance patient outcomes.

Collaborations

Wen-Chun Kuo collaborates with Henrich Cheng, who is a key figure in his research endeavors. Their partnership exemplifies the collaborative spirit in the field of biotechnology, driving forward innovative solutions.

Conclusion

Wen-Chun Kuo's contributions to biotechnology, particularly through his patented innovations, highlight the importance of research and collaboration in advancing medical science. His work continues to pave the way for future developments in the field.